Ameriprise’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $730M | Sell |
|
|||||
2025
Q1 | $845M | Buy |
|
|||||
2024
Q4 | $706M | Sell |
|
|||||
2024
Q3 | $1.97B | Sell |
|
|||||
2024
Q2 | $2.05B | Buy |
|
|||||
2024
Q1 | $1.87B | Sell |
|
|||||
2023
Q4 | $1.75B | Buy |
|
|||||
2023
Q3 | $1.43B | Sell |
|
|||||
2023
Q2 | $1.66B | Buy |
|
|||||
2023
Q1 | $1.66B | Buy |
|
|||||
2022
Q4 | $1.65B | Buy |
|
|||||
2022
Q3 | $1.38B | Buy |
|
|||||
2022
Q2 | $1.43B | Buy |
|
|||||
2022
Q1 | $1.43B | Buy |
|
|||||
2021
Q4 | $1.14B | Buy |
|
|||||
2021
Q3 | $534M | Buy |
|
|||||
2021
Q2 | $293M | Sell |
|
|||||
2021
Q1 | $299M | Sell |
|
|||||
2020
Q4 | $279M | Sell |
|
|||||
2020
Q3 | $300M | Sell |
|
|||||
2020
Q2 | $296M | Buy |
|
|||||
2020
Q1 | $212M | Buy |
|
|||||
2019
Q4 | $277M | Buy |
|
|||||
2019
Q3 | $188M | Sell |
|
|||||
2019
Q2 | $365M | Buy |
|
|||||
2019
Q1 | $267M | Sell |
|
|||||
2018
Q4 | $397M | Sell |
|
|||||
2018
Q3 | $536M | Sell |
|
|||||
2018
Q2 | $447M | Buy |
|
|||||
2018
Q1 | $259M | Buy |
|
|||||
2017
Q4 | $241M | Sell |
|
|||||
2017
Q3 | $248M | Sell |
|
|||||
2017
Q2 | $344M | Sell |
|
|||||
2017
Q1 | $331M | Sell |
|
|||||
2016
Q4 | $290M | Sell |
|
|||||
2016
Q3 | $325M | Buy |
|
|||||
2016
Q2 | $216M | Buy |
|
|||||
2016
Q1 | $25.8M | Sell |
|
|||||
2015
Q4 | $34.6M | Sell |
|
|||||
2015
Q3 | $95M | Sell |
|
|||||
2015
Q2 | $352M | Sell |
|
|||||
2015
Q1 | $343M | Sell |
|
|||||
2014
Q4 | $314M | Buy |
|
|||||
2014
Q3 | $287M | Sell |
|
|||||
2014
Q2 | $267M | Buy |
|
|||||
2014
Q1 | $202M | Buy |
|
|||||
2013
Q4 | $150M | Buy |
|
|||||
2013
Q3 | $26.2M | Buy |
|
|||||
2013
Q2 | $18.2M | Buy |
|